SEBI Reg. Investment Advisor

Download App
Help Center Subscribe
Money Works 4 Me Logo MoneyWorks4Me
Talk to Advisor
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

Modern Diagnostic & Research Centre Ltd (544673)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 544673 NSE: Hospital & Healthcare Services | Small Cap | Modern Diagnostic Share Price

₹52 0.00 (0.00%)

As on 24-Jun'26 16:59

Modern Diagnostic & Research Centre Ltd (544673)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 544673 NSE: Hospital & Healthcare Services | Small Cap | Modern Diagnostic Share Price

₹52 0.00 (0.00%)

As on 24-Jun'26 16:59

Key Metrics
Valuation Multiples
Market Cap
₹79 Cr.
Current Price
₹52
52-Week Low / High
₹50 / 100
TTM EPS
₹3.5
TTM Sales
₹83.1 Cr.
Book Value per Share
₹38.2
P/E Ratio
14.95
Higher than its 5-year historical median
Industry PE
91.4
Price to Book (P/B)
1.36
Lower than its 5-year historical median
Price to Sales (P/S)
0.94
Lower than its 5-year historical median
EV/EBITDA
7.33
In line with its 5-year historical median
Dividend Yield
0%
Profitability Efficiency
Return on Equity (ROE)
55.21%
Outperforms industry median
Return on Capital Employed (ROCE)
39.00%
Outperforms industry median
Return on Assets (ROA)
15.73%
Operating Profit Margin
23%
Net Profit Margin
11.51%
Gross Profit Margin
21.7%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
16.12%
Operating Profit Growth (1 Year)
Improving versus 3-year growth rate
62.53%
Net Profit Growth (1 Year)
-
54.92%
Asset Quality
Promoter Holding
72.85%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹43 Cr.
Equity
₹15.1 Cr.
Face Value
₹10
All Time Low / High
₹50.10 / 100.00

Modern Diagnostic & Research Centre stock performance

Key Ratios
mw4me loader

Check Before You Invest

Check Before You Invest

M-Cap below 100cr DeciZen not available

Q.1 Is Modern Diagnostic & Research Centre Ltd a good quality company?
Modern Diagnostic & Research Centre Ltd is a weak quality company, based on a inconsistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

View More

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

View More
How does Modern Diagnostic & Research Centre Ltd performance compare with that of its Peers?
Q.1 Revenue growth of Modern Diagnostic & Research Centre Ltd vs industry peers?
Modern Diagnostic & Research Centre Ltd revenue CAGR is 8.99%, compared to the industry median CAGR of 6.53%, indicating faster growth and gaining its market share.
Q.1 Promoter shareholding and pledge status of Modern Diagnostic & Research Centre Ltd?
Promoters hold 72.85% of the Modern Diagnostic & Research Centre Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Q.1 Stock return of Modern Diagnostic & Research Centre Ltd over the last decade?
Over the last - year(s), the stock has delivered a CAGR of N/A% based on the current price.
View More

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Modern Diagnostic & Research Centre Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation ⓘ

Mar'22Mar'23Mar'24Mar'25TTM
ROCE % ⓘ8.4%-17%32.4%39%-
Value Creation
Index ⓘ		-0.4-2.21.31.8-

Growth Parameters ⓘ
Sales ⓘ60.256.367.17883
Sales YoY Gr.--6.5%19.3%16.1%-
Adj EPS ⓘ-1.3-5.35.38.13.5
YoY Gr.-NANA53%-
BVPS (₹) ⓘ10.65.410.718.838.2
Adj Net
Profit ⓘ		-1.4-5.85.995
Cash Flow from Ops. ⓘ3.6-0.17.913.7-
Debt/CF from Ops. ⓘ5.6-128.82.61.6-

CAGR ⓘ

9 Years 5 Years 3 Years 1 Years
Sales ⓘNANA9%16.1%
Adj EPS ⓘNANANA53%
BVPSⓘNANA21%76.2%
Share Price - - - -

Key Financial Parameters ⓘ

Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity % ⓘ		-12.3-65.86655.212.2
Op. Profit
Mgn % ⓘ		10-1.816.623.1NAN
Net Profit
Mgn % ⓘ		-2.4-10.38.711.56.3
Debt to
Equity ⓘ		1.72.61.71.1-
Working Cap
Days ⓘ		08584990
Cash Conv.
Cycle ⓘ		0-11-590

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24Mar'25
Sales60.2156.2867.1377.95
Operating Expenses ⓘ + 54.2157.2756.0859.98
Manufacturing Costs2.453.133.503.95
Material Costs21.2817.5217.6418.81
Employee Cost 12.8415.1715.7017.93
Other Costs ⓘ 17.6421.4419.2519.29
Operating Profit ⓘ 5.99-0.9911.0517.96
Operating Profit Margin (%) 10.0%-1.8%16.5%23.0%
Other Income ⓘ + 0.370.321.540.86
Exceptional Items ⓘ 0000
Interest ⓘ 1.571.411.811.91
Depreciation ⓘ 3.663.873.924.19
Profit Before Tax ⓘ 1.14-5.946.8612.72
Tax ⓘ 2.59-0.211.073.76
Profit After Tax -1.45-5.735.798.97
PAT Margin (%) -2.4%-10.2%8.6%11.5%
Adjusted EPS (₹)-1.3-5.25.38.2
Dividend Payout Ratio (%)0%0%0%0%

Valuation of Modern Diagnostic - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund + 11.705.9611.7620.73
Share Capital ⓘ 11111
Reserves ⓘ 10.704.9610.769.73
Debt +18.2812.7617.5817.66
Long Term Debt13.245.8110.148.30
Short Term Debt5.046.957.449.36
Minority Interest0000
Trade Payables10.058.208.568.26
Others Liabilities ⓘ 8.679.6211.5817.93
Total Liabilities ⓘ 48.7036.5449.4964.57

Fixed Assets

Net Fixed Assets ⓘ +24.3123.6727.0430.65
Gross Block50.5553.0359.7967.54
Accumulated Depreciation26.2429.3632.7536.89
CWIP ⓘ 0.7503.608.95
Investments ⓘ 5.290.110.210.23
Inventories1.511.952.974.92
Trade Receivables98.0610.3512.76
Cash Equivalents 4.640.150.410.78
Others Assets ⓘ 3.192.594.906.28
Total Assets ⓘ 48.7036.5449.4964.57

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity ⓘ + 3.64-0.127.9313.73
PBT ⓘ 1.14-5.946.8612.72
Adjustment ⓘ 4.755.105.756.01
Changes in Working Capital ⓘ -2.740.73-5.95-1.21
Tax Paid ⓘ 0.4901.26-3.79
Cash Flow From Investing Activity ⓘ + -5.202.11-11.03-13.14
Capex -5.13-3.16-10.97-13.15
Net Investments -0.435.18-0.09-0.02
Others ⓘ 0.360.090.030.03
Cash Flow From Financing Activity ⓘ + 4.50-6.473.36-0.22
Net Proceeds from Shares ⓘ 0000
Net Proceeds from Borrowing ⓘ 0.10-7.434.33-1.83
Interest Paid ⓘ -1.43-1.38-1.79-1.85
Dividend Paid ⓘ 0000
Others ⓘ 5.832.340.823.47
Net Cash Flow ⓘ 2.94-4.480.260.37

Financial Ratio

PARTICULARSMar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)-12.41-64.9265.455.21
ROCE (%)8.43-16.9832.4239
Asset Turnover Ratio1.241.321.561.37
PAT to CFO Conversion(x)N/AN/A1.371.53
Working Capital Days
Receivable Days54.6055.3050.1054.10
Inventory Days9.2011.2013.4018.50
Payable Days172.40190.10173.40163.20

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Modern Diagnostic & Research Centre Ltd FAQs

The current trading price of Modern Diagnostic on 24-Jun-2026 16:59 is ₹52.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 23-Jun-2026 the market cap of Modern Diagnostic stood at ₹78.52 Cr

The latest P/E ratio of Modern Diagnostic as of 23-Jun-2026 is 14.95.

The latest P/B ratio of Modern Diagnostic as of 23-Jun-2026 is 1.36.

The 52-week high of Modern Diagnostic is ₹100.0 and the 52-week low is ₹50.10.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Modern Diagnostic is ₹83.11 ( Cr.) .

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Modern Diagnostic & Research Centre Ltd is a below average quality company.

The key valuation ratios of Modern Diagnostic & Research Centre Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Modern Diagnostic & Research Centre Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Modern Diagnostic & Research Centre Ltd

Modern Diagnostic & Research Centre was originally incorporated as ‘Modern Diagnostic & Research Centre Private Limited’ as a private limited company, on April 16, 2012. Subsequently, the company was converted from a private limited company to public limited company pursuant to special resolution passed in the Extraordinary General Meeting of the company held on November 16, 2024 and consequently the name of the company was changed to ‘Modern Diagnostic & Research Centre Limited’.

The company is a services provider in diagnostic and related healthcare tests services in India. Through its integrated nationwide network, it offers a complete range of diagnostic facilities in radiology and pathology. It provides healthcare tests and services for use in core testing, patients’ diagnosis and prevention, monitoring of disease and other health conditions. Its customers include individual patients, hospitals and other healthcare providers and corporate customers. The company is focused on providing reliable diagnostic and related healthcare tests and value-added services such as home collection of specimens and online access to test reports. It also offers customized test packages to its institutional customers/patients as per their requirement. The company’s patient centric approach is a critical differentiator which results in several individuals and healthcare providers choosing it as their diagnostic healthcare services provider.

It has also implemented a PACS (Picture Archiving and Communication System) for efficient data storage, retrieval, and management of medical images. This advanced system allows the company to securely store diagnostic images such as X-rays, CT scans, MRIs, and ultrasounds in a digital format, eliminating the need for physical film. Additionally, PACS enables seamless remote access to medical images and reports via the internet. This allows radiologists and healthcare professionals to analyze and interpret diagnostic images from any location, improving workflow efficiency and ensuring faster reporting. With this system, patient data remains securely stored while providing quick and convenient access for accurate diagnosis and timely medical decisions.

Business area of the company 

The company is a services provider in diagnostic and related healthcare tests services in India. Through its integrated nationwide network, it offers a complete range of diagnostic facilities in radiology and pathology. 

Services of the company

  • Pathology: The company’s comprehensive pathology services cover multiple specialties, including Haematology, Biochemistry, Clinical Pathology, Serology, Immunology, Histopathology, Cytopathology, Microbiology, Molecular Diagnostics, and Genetic Testing. It offers a wide range of diagnostic tests, such as Complete Blood Counts (CBC), Liver and Kidney Function Tests (LFT/KFT), Lipid Profiles, Hormone Analysis, Autoimmune Disease Markers, Cancer Screening, and Infectious Disease Testing. Additionally, its advanced molecular diagnostics capabilities, including PCR, RT-PCR, Next-Generation Sequencing (NGS), and Oncogene Testing, and LC-MS/MS based tests enable early detection of genetic disorders and chronic diseases.
  • Radiology: The company offers a comprehensive range of radiology services, including MRI (1.5T and 3T), CT scans, ultrasound, color Doppler studies, digital X-rays, mammography, and interventional radiology. It also specializes in advanced diagnostic techniques such as digital mammography for breast cancer detection, DEXA scans for osteoporosis screening, and fluoroscopic imaging for gastrointestinal studies. Its interventional radiology services provide minimally invasive, image-guided procedures, including biopsies, drainage, and reducing the need for surgery.

Awards, accreditations and recognition 

  • 2014: Brand Academy - Healthcare Excellence Awards.
  • 2015: Brand Academy - Global Quality Awards.
  • 2018: Times Healthcare Achievers Awards 2018 by BCCL.
  • 2019: Indian Business Excellence Awards 2019 by WBR Corp UK Limited.

History and milestones

  • 2012-13: Incorporation of the company in the name and style of ‘Modern Diagnostic & Research Centre Private Limited’.
  • 2013-14: Acquisition of Business of M/s Modern Diagnostics & Research Centre, Proprietorship Concern through Business Transfer Agreement. Proprietorship Concern was engaged in the business of Diagnostic Centre.
  • 2024-25: Converted into Public Limited Company in the name and style of ‘Modern Diagnostic & Research Centre Limited’.

You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: